The Histone Modifier KAT2A Presents a Selective Target in a Subset of Well-Differentiated Microsatellite-Stable Colorectal Cancers

Investigators elucidated the molecular underpinnings of lysine acetyltransferase 2 A (KAT2A) dependency in CRC and assessed the consequences of KAT2A depletion.